Approved for NOVOLIN 70/30 is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Limitations of Use: In NOVOLIN 70/30, the proportions of short-acting and intermediate-acting insulins are fixed and do not allow for basal versus prandial dose adjustments.. The primary activity of insulin, including NOVOLIN 70/30, is the regulation of glucose metabolism.…
Loading full data from Know Your Drugs Institute…